Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $87.7600 (1.99%) ($86.0600 - $87.8750) on Mon. Nov. 25, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.27% (three month average) | RSI | 78 | Latest Price | $87.7600(1.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.2% a day on average for past five trading days. | Weekly Trend | ABBV advances 2.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(63%) SPLV(53%) VYM(53%) DIA(52%) IVE(52%) | Factors Impacting ABBV price | ABBV will decline at least -0.635% in a week (0% probabilities). VIXM(-36%) TLT(-15%) VXX(-14%) IGOV(-4%) UUP(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.635% (StdDev 1.27%) | Hourly BBV | 0 () | Intraday Trend | 0.9% | | | |
|
5 Day Moving Average | $87.31(0.52%) | 10 Day Moving Average | $87.46(0.34%) | 20 Day Moving Average | $84.88(3.39%) | To recent high | -1.4% | To recent low | 34.2% | Market Cap | $154.833b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |